MEsoblast and others have these for their products. It's essentially step 1 towards trying to get accelerated approval when strong results are in or pending but it's by no means in the bag.
https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/priority-review
It just means if they submit an application the FDA will look at it twice as fast as a normal application (within 6 months instead of 10 I think.
MSB has had one for its products for over a year and still no approval yet but it's a positive sign.
Given PTX are not close to approval with a P3 trial outcome it seems unlikely soon however, as @MrGold points out, they could get a pharma partnership or major re-rating based on the market figuring it is a likely outcome, or worth backing in case it does you know..... end up as a cure for certain types of cancer!
- Forums
- ASX - By Stock
- peter Mac
MEsoblast and others have these for their products. It's...
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.43M |
Open | High | Low | Value | Volume |
4.5¢ | 4.5¢ | 4.3¢ | $36.04K | 810.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 974 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 0.044 |
1 | 330000 | 0.043 |
1 | 10000 | 0.042 |
3 | 246000 | 0.041 |
7 | 925642 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 974 | 1 |
0.047 | 63339 | 2 |
0.049 | 114091 | 2 |
0.050 | 236935 | 5 |
0.051 | 19607 | 1 |
Last trade - 13.57pm 04/10/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |